Search Results - "MASAMURA, Katsuhiko"

Long-Term Outcomes in Elderly Patients After Deferral of Coronary Revascularization Guided by Fractional Flow Reserve by Ueki, Yasushi, Kuramitsu, Shoichi, Saigusa, Tatsuya, Senda, Keisuke, Matsuo, Hitoshi, Horie, Kazunori, Takashima, Hiroaki, Terai, Hidenobu, Kikuta, Yuetsu, Ishihara, Takayuki, Sakamoto, Tomohiro, Suematsu, Nobuhiro, Shiono, Yasutsugu, Asano, Taku, Tsujita, Kenichi, Masamura, Katsuhiko, Doijiri, Tatsuki, Sasaki, Yohei, Ogita, Manabu, Kurita, Tairo, Matsuo, Akiko, Harada, Ken, Yaginuma, Kenji, Kanemura, Noriyoshi, Sonoda, Shinjo, Yokoi, Hiroyoshi, Tanaka, Nobuhiro, on behalf of the J-CONFIRM Investigators

“…Background: Little evidence is available regarding the long-term outcome in elderly patients after deferral of revascularization based on fractional flow…”
Get full text

Five-Year Outcomes After Fractional Flow Reserve–Based Deferral of Revascularization in Chronic Coronary Syndrome: Final Results From the J-CONFIRM Registry by Kuramitsu, Shoichi, Matsuo, Hitoshi, Shinozaki, Tomohiro, Horie, Kazunori, Takashima, Hiroaki, Terai, Hidenobu, Kikuta, Yuetsu, Ishihara, Takayuki, Saigusa, Tatsuya, Sakamoto, Tomohiro, Suematsu, Nobuhiro, Shiono, Yasutsugu, Asano, Taku, Tsujita, Kenichi, Masamura, Katsuhiko, Doijiri, Tatsuki, Toyota, Fumitoshi, Ogita, Manabu, Kurita, Tairo, Matsuo, Akiko, Harada, Ken, Yaginuma, Kenji, Sonoda, Shinjo, Yokoi, Hiroyoshi, Tanaka, Nobuhiro

“…Little large-scale data is available about the long-term (beyond 3 years) clinical outcomes after fractional flow reserve (FFR)-based deferral of…”
Get full text

Prognostic Impact of Renal Function on 5-Year Outcomes After Fractional Flow Reserve-Guided Deferral of Revascularization by Itakura, Ryosuke, Kuramitsu, Shoichi, Kikuchi, Jun, Kawase, Yoshiaki, Mizukami, Takuya, Shinozaki, Tomohiro, Horie, Kazunori, Takashima, Hiroaki, Terai, Hidenobu, Kikuta, Yuetsu, Ishihara, Takayuki, Saigusa, Tatsuya, Sakamoto, Tomohiro, Suematsu, Nobuhiro, Shiono, Yasutsugu, Asano, Taku, Tsujita, Kenichi, Masamura, Katsuhiko, Doijiri, Tatsuki, Toyota, Fumitoshi, Ogita, Manabu, Kurita, Tairo, Matsuo, Akiko, Harada, Ken, Yaginuma, Kenji, Sonoda, Shinjo, Yokoi, Hiroyoshi, Tanaka, Nobuhiro, Matsuo, Hitoshi

“…Background Chronic kidney disease (CKD) might influence fractional flow reserve (FFR) value, potentially attenuating its prognostic utility. However, few…”
Get full text

Pitavastatin-Induced Thrombomodulin Expression by Endothelial Cells Acts Via Inhibition of Small G Proteins of the Rho Family by Masamura, Katsuhiko, Oida, Koji, Kanehara, Hideo, Suzuki, Jinya, Horie, Shuichi, Ishii, Hidemi, Miyamori, Isamu

“…OBJECTIVE—3-Hydroxyl-3-methyl coenzyme A reductase inhibitors (statins) can function to protect the vasculature in a manner that is independent of their…”
Get full text

Diagnostic use of serum deoxyribonuclease I activity as a novel early-phase marker in acute myocardial infarction by KAWAI, Yasuyuki, YOSHIDA, Masahiro, TANIGUCHI, Koichi, TERASAWA, Hidekazu, MIYAMORI, Isamu, KISHI, Koichiro, YASUDA, Toshihiro, ARAKAWA, Kenichiro, KUMAMOTO, Teruhiko, MORIKAWA, Norihiro, MASAMURA, Katsuhiko, TADA, Hiroshi, ITO, Sachiko, HOSHIZAKI, Hiroshi, OSHIMA, Shigeru

“…The delayed release of serum cardiac markers such as creatine kinase isoenzyme MB and equivocal early electrocardiographic changes have hampered a diagnosis of…”
Get full text

Impact of Antiplatelet Therapy on 5-Year Outcomes After Fractional Flow Reserve-Guided Deferral of Revascularization in Nonsignificant Obstructive Coronary Artery Disease by Kurita, Tairo, Kuramitsu, Shoichi, Ishii, Masanobu, Takasaki, Akihiro, Domei, Takenori, Matsuo, Hitoshi, Horie, Kazunori, Ando, Hirohiko, Terai, Hidenobu, Kikuta, Yuetsu, Ishihara, Takayuki, Saigusa, Tatsuya, Sakamoto, Tomohiro, Suematsu, Nobuhiro, Shiono, Yasutsugu, Asano, Taku, Tsujita, Kenichi, Masamura, Katsuhiko, Doijiri, Tatsuki, Toyota, Fumitoshi, Ogita, Manabu, Shiraishi, Jun, Harada, Ken, Isogai, Hiroyuki, Anai, Reo, Sonoda, Shinjo, Yokoi, Hiroyoshi, Tanaka, Nobuhiro, Dohi, Kaoru, on behalf of the J-CONFIRM Investigators

“…Background: Because the clinical benefit of antiplatelet therapy (APT) for patients with nonsignificant coronary artery disease (CAD) remains poorly…”
Get full text

Sex Differences in 5-Year Outcomes After Deferral of Revascularization Following Physiological Coronary Assessment by Ishihara, Takayuki, Kuramitsu, Shoichi, Matsuo, Hitoshi, Horie, Kazunori, Takashima, Hiroaki, Terai, Hidenobu, Kikuta, Yuetsu, Saigusa, Tatsuya, Sakamoto, Tomohiro, Suematsu, Nobuhiro, Shiono, Yasutsugu, Asano, Taku, Tsujita, Kenichi, Masamura, Katsuhiko, Doijiri, Tatsuki, Toyota, Fumitoshi, Ogita, Manabu, Kurita, Tairo, Matsuo, Akiko, Harada, Ken, Yaginuma, Kenji, Sonoda, Shinjo, Yokoi, Hiroyoshi, Tanaka, Nobuhiro, Mano, Toshiaki, on behalf of the J-CONFIRM Investigators

“…Background: The relationship between sex differences and long-term outcomes after fractional flow reserve (FFR)- and instantaneous wave-free ratio (iFR)-guided…”
Get full text

Two-Year Outcomes of Asymptomatic vs. Symptomatic Patients After Deferral of Revascularization Based on Fractional Flow Reserve　― Insights From the J-CONFIRM Registry by Horie, Kazunori, Kuramitsu, Shoichi, Matsuo, Hitoshi, Shinozaki, Tomohiro, Takashima, Hiroaki, Shiono, Yasutsugu, Terai, Hidenobu, Kikuta, Yuetsu, Ishihara, Takayuki, Saigusa, Tatsuya, Sakamoto, Tomohiro, Asano, Taku, Tsujita, Kenichi, Masamura, Katsuhiko, Doijiri, Tatsuki, Ogita, Manabu, Kurita, Tairo, Matsuo, Akiko, Sonoda, Shinjo, Yokoi, Hiroyoshi, Tanaka, Nobuhiro, on behalf of the J-CONFIRM Investigators

“…Background:The effect of symptoms on clinical outcomes after deferral of revascularization based on fractional flow reserve (FFR) remains poorly…”
Get full text

Two-Year Outcomes After Deferral of Revascularization Based on Fractional Flow Reserve: The J-CONFIRM Registry by Kuramitsu, Shoichi, Matsuo, Hitoshi, Shinozaki, Tomohiro, Horie, Kazunori, Takashima, Hiroaki, Terai, Hidenobu, Kikuta, Yuetsu, Ishihara, Takayuki, Saigusa, Tatsuya, Sakamoto, Tomohiro, Suematsu, Nobuhiro, Shiono, Yasutsugu, Mizuno, Atsushi, Tsujita, Kenichi, Masamura, Katsuhiko, Yokoi, Hiroyoshi, Tanaka, Nobuhiro

“…The safety of fractional flow reserve (FFR)-based deferral of revascularization remains to be fully established in real-world practice. We sought to assess…”
Get full text

Thrombotic Risk and Cardiovascular Events in Patients With Revascularization Deferral After Fractional Flow Reserve Assessment by Shiono, Yasutsugu, Kuramitsu, Shoichi, Matsuo, Hitoshi, Horie, Kazunori, Takashima, Hiroaki, Terai, Hidenobu, Kikuta, Yuetsu, Ishihara, Takayuki, Saigusa, Tatsuya, Sakamoto, Tomohiro, Suematsu, Nobuhiro, Asano, Taku, Tsujita, Kenichi, Masamura, Katsuhiko, Doijiri, Tatsuki, Toyota, Fumitoshi, Ogita, Manabu, Kurita, Tairo, Matsuo, Akiko, Harada, Ken, Yaginuma, Kenji, Sonoda, Shinjo, Tanaka, Atsushi, Yokoi, Hiroyoshi, Tanaka, Nobuhiro

“…The aim of this study was to evaluate the impact of thrombotic risk on the occurrence of cardiovascular events in patients with coronary artery disease with…”
Get full text

Long-Term Outcomes in Elderly Patients After Deferral of Coronary Revascularization Guided by Fractional Flow Reserve by Ueki, Yasushi, Kuramitsu, Shoichi, Saigusa, Tatsuya, Senda, Keisuke, Matsuo, Hitoshi, Horie, Kazunori, Takashima, Hiroaki, Terai, Hidenobu, Kikuta, Yuetsu, Ishihara, Takayuki, Sakamoto, Tomohiro, Suematsu, Nobuhiro, Shiono, Yasutsugu, Asano, Taku, Tsujita, Kenichi, Masamura, Katsuhiko, Doijiri, Tatsuki, Sasaki, Yohei, Ogita, Manabu, Kurita, Tairo, Matsuo, Akiko, Harada, Ken, Yaginuma, Kenji, Kanemura, Noriyoshi, Sonoda, Shinjo, Yokoi, Hiroyoshi, Tanaka, Nobuhiro, on behalf of the J-CONFIRM Investigators

“…Background:Little evidence is available regarding the long-term outcome in elderly patients after deferral of revascularization based on fractional flow…”
Get full text

Five-Year Outcomes After Fractional Flow Reserve–Based Deferral of Revascularization in Chronic Coronary Syndrome: Final Results From the J-CONFIRM Registry by Kuramitsu, Shoichi, Matsuo, Hitoshi, Shinozaki, Tomohiro, Horie, Kazunori, Takashima, Hiroaki, Terai, Hidenobu, Kikuta, Yuetsu, Ishihara, Takayuki, Saigusa, Tatsuya, Sakamoto, Tomohiro, Suematsu, Nobuhiro, Shiono, Yasutsugu, Asano, Taku, Tsujita, Kenichi, Masamura, Katsuhiko, Doijiri, Tatsuki, Toyota, Fumitoshi, Ogita, Manabu, Kurita, Tairo, Matsuo, Akiko, Harada, Ken, Yaginuma, Kenji, Sonoda, Shinjo, Yokoi, Hiroyoshi, Tanaka, Nobuhiro

Get full text

Effects of Brief Glucocorticoid Exposure on Growth of Vascular Smooth Muscle Cells in Culture by Kawai, Yasuyuki, Hayashi, Takio, Eguchi, Katsuya, Asazuma, Ken-ya, Masamura, Katsuhiko, Iwamuro, Ayumi, Takano, Youichi, Tada, Hiroshi, Matsukawa, Shigeru, Miyamori, Isamu

“…While prolonged exposure of vascular smooth muscle cells (VSMC) to glucocorticoid has been shown to inhibit cell proliferation, the effect of a brief pulse…”
Get full text

Five-Year Outcomes After Fractional Flow Reserve–Guided Deferral of Revascularization in Infarct-Related Artery Lesions by Ohashi, Hirofumi, Kuramitsu, Shoichi, Takashima, Hiroaki, Matsuo, Hitoshi, Horie, Kazunori, Terai, Hidenobu, Kikuta, Yuetsu, Ishihara, Takayuki, Saigusa, Tatsuya, Sakamoto, Tomohiro, Suematsu, Nobuhiro, Shiono, Yasutsugu, Asano, Taku, Tsujita, Kenichi, Masamura, Katsuhiko, Doijiri, Tatsuki, Sasaki, Yohei, Ogita, Manabu, Kurita, Tairo, Matsuo, Akiko, Harada, Ken, Yaginuma, Kenji, Sonoda, Shinjo, Amano, Tetsuya, Yokoi, Hiroyoshi, Tanaka, Nobuhiro

“…Little evidence is available about the long-term safety of fractional flow reserve (FFR)-guided deferral of revascularization in infarct-related artery (IRA)…”
Get full text

Association of guideline-directed medical therapy adherence with outcomes after fractional flow reserve-based deferral of revascularization by Ishii, Masanobu, Kuramitsu, Shoichi, Yamanaga, Kenshi, Matsuo, Hitoshi, Horie, Kazunori, Takashima, Hiroaki, Terai, Hidenobu, Kikuta, Yuetsu, Ishihara, Takayuki, Saigusa, Tatsuya, Sakamoto, Tomohiro, Suematsu, Nobuhiro, Shiono, Yasutsugu, Asano, Taku, Masamura, Katsuhiko, Doijiri, Tatsuki, Toyota, Fumitoshi, Ogita, Manabu, Kurita, Tairo, Matsuo, Akiko, Harada, Ken, Yaginuma, Kenji, Kanemura, Noriyoshi, Sonoda, Shinjo, Yokoi, Hiroyoshi, Tanaka, Nobuhiro, Tsujita, Kenichi

“…Abstract Aims Guideline-directed medical therapy (GDMT) is essential to prevent future cardiovascular events in chronic coronary syndrome (CCS) patients…”
Get full text

Mineralocorticoid receptor is overexpressed in cardiomyocytes of patients with congestive heart failure by Yoshida, Masahiro, Ma, Jun, Tomita, Tsutomu, Morikawa, Norihiro, Tanaka, Nobuyoshi, Masamura, Katsuhiko, Kawai, Yasuyuki, Miyamori, Isamu

“…Mineralocorticoid receptors (MRs) have been identified in the human cardiovascular tissues. We determined MR expression in the failing heart to clarify the…”
Get more information

Amphiregulin is a potent mitogen for the vascular smooth muscle cell line, A7r5 by Kato, Masayuki, Inazu, Tetsuya, Kawai, Yasuyuki, Masamura, Katsuhiko, Yoshida, Masahiro, Tanaka, Nobuyoshi, Miyamoto, Kaoru, Miyamori, Isamu

“…The regulation of amphiregulin, an epidermal growth factor (EGF) family member, and its effect on vascular smooth muscle cells (VSMC) were examined…”
Get full text

A role of heparin-binding epidermal growth factor-like growth factor in cardiac remodeling after myocardial infarction by Tanaka, Nobuyoshi, Masamura, Katsuhiko, Yoshida, Masahiro, Kato, Masayuki, Kawai, Yasuyuki, Miyamori, Isamu

“…Heparin-binding epidermal growth factor-like growth factor (HB-EGF) is known to induce cell growth in various cell types via transactivation of epidermal…”
Get full text

Impact of Antiplatelet Therapy on 5-Year Outcomes After Fractional Flow Reserve-Guided Deferral of Revascularization in Nonsignificant Obstructive Coronary Artery Disease by Kurita, Tairo, Kuramitsu, Shoichi, Ishii, Masanobu, Takasaki, Akihiro, Domei, Takenori, Matsuo, Hitoshi, Horie, Kazunori, Ando, Hirohiko, Terai, Hidenobu, Kikuta, Yuetsu, Ishihara, Takayuki, Saigusa, Tatsuya, Sakamoto, Tomohiro, Suematsu, Nobuhiro, Shiono, Yasutsugu, Asano, Taku, Tsujita, Kenichi, Masamura, Katsuhiko, Doijiri, Tatsuki, Toyota, Fumitoshi, Ogita, Manabu, Shiraishi, Jun, Harada, Ken, Isogai, Hiroyuki, Anai, Reo, Sonoda, Shinjo, Yokoi, Hiroyoshi, Tanaka, Nobuhiro, Dohi, Kaoru, on behalf of the J-CONFIRM Investigators

“…Background: Because the clinical benefit of antiplatelet therapy (APT) for patients with nonsignificant coronary artery disease (CAD) remains poorly…”
Get full text

Evidence of macrophage foam cell formation by very low-density lipoprotein receptor : Interferon-γ inhibition of very low-density lipoprotein receptor expression and foam cell formation in macrophages by KOSAKA, Shotaro, TAKAHASHI, Sadao, KODAMA, Tatsuhiko, YAMAMOTO, Tokuo, MIYAMORI, Isamu, MASAMURA, Katsuhiko, KANEHARA, Hideo, SAKAI, Juro, TOHDA, Gen, OKADA, Eiko, OIDA, Koji, IWASAKI, Tadao, HATTORI, Hiroaki

“…Expression of the VLDL receptor, primarily in macrophages, has been confirmed in human and rabbit atherosclerotic lesions. The high binding affinity of the…”
Get full text